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Introduction 
 Chronic tonsillitis (CT) occupies a leading place 
in the structure of general Oto-rhino-laryngology (ORL) 
pathology which is characterized by a tendency to an 
increase in the number of patients with recurrent course, the 
development of complications and the diversity of 
etiopathogenetic mechanisms of onset. Among the medico-
social tasks that determine the scientific and practical 
strategy in solving CT, the central place belongs to the search 
for adequate, safe and effective methods of treatment and 
rehabilitation of patients with CT. After all, an impressive 
arsenal of current therapeutic tactics used in CT therapy, 
cannot effectively alleviate this pathology [1, 2]. 
 In the pathogenesis of chronic tonsillitis, the 
disturbance of the microbiota of the mucous membranes of 
the tonsils is of great importance since the oropharynx is an 
ecological system in which external factors interact 
dynamically with the internal ones while maintaining an 
equilibrium state. Indigenous microflora of a person has a 
number of vital functions, the main ones of which are 
colonization resistance, the stimulation of hereditary and 
adaptive immunity, detoxification, etc. Any stress factor that 
affects the microflora that normally forms the 
microbiocenosis of a particular biotope can lead to a loss of 
tolerance of the immune system to the microflora and 
development of the immune response [3, 4]. 
 It has been established that the most acceptable 
tactic for the prevention of exacerbations of chronic 
tonsillitis is the use of various groups of drugs that enhance 
the humoral immunity of the mucous membranes, for 
example, ribomunil, imupret, which are applied orally, or by 
prophylactic vaccination with drugs lysates from bacteria 
(type IRS 19, imudon, bronhovax, bronchomunal) [5-7]. 
 The drug Ismigen (certificate of state registration 
of a medical immunobiological drug in Ukraine No. 
UA/15678/01/01, Order of the Ministry of Health of Ukraine 
of December 22, 2016 №. 1391) is an immunostimulant 
based on a bacterial lysate, which increases the body's 
resistance to infections due to an increase in serum and 
secretory antibodies, activation of cellular and humoral 
factors of nonspecific immunity. 
 Bacterial lysates of 13 bacteria (Staphylococcus 
aureus, Streptococcus pyogenes, Streptococcus viridans, 
Klebsiella pneumoniae, Klebsiella ozaenae, Haemophillus 
influenza, Moraxella catarrhalis and 6 types of pneumococci 
(Streptococcus pneumoniae) that form part of Ismigen are 
obtained by mechanical lysis, which gives certain 
advantages over others immunomodulators, which include 
chemical lysates. With mechanical lysis, antigenic 
structures, in particular corpuscular antigens, are more fully 
preserved, which provides a long-term immune response. 
Evaluation of the use of Imigen/Respibron® compared to 
chemical lysate in patients with lower respiratory tract 
infections showed statistically significant differences in the 
efficacy of mechanical lysates [8]. Results of randomized 
clinical trials in 2557 patients showed that the use of 
mechanical bacterial lysates induces a significant reduction 
in recurrence of infections in both children and adults [9]. 
 In previous studies, we showed that in patients 
suffering from chronic decompensated tonsillitis, micro-
ecological disturbances of the normal biocenosis of the tonsil 
mucosa are observed. Elimination of the indigenous 
microflora leads to colonization of the biotope by pathogenic 
and opportunistic microorganisms, which aggravates the 
course of the underlying disease [10]. 
 The foregoing study shows that the use of  
Ismigen in the complex treatment of patients with chronic 
decompensated tonsillitis seems to be relevant. 
 The aim of the study was to evaluate the 
effectiveness of the use of Ismigen in the complex treatment 
of patients with chronic decompensated tonsillitis by 
studying the dynamics of microbiological indicators. 
 
Materials and methods 
 To achieve this goal, 31 patients with chronic 
decompensated tonsillitis (CDT) (according to I.B. 
Soldatov's classification, 1975) were examined. Patients 
involved in the study did not take antimicrobial drugs for 
three months and had no other medical pathology other than 
the one examined. Patients were divided into 2 groups 
depending on the proposed treatment regimen: 
Group A: patients with chronic decompensated tonsillitis 
who underwent laser tonsillotomy - 15 patients; 
Group B: patients with chronic decompensated tonsillitis 
who underwent laser tonsillotomy with further 
immunostimulation with the drug Ismigen - 16 patients. 
 The control group (CG) consisted of 17 
practically healthy individual who had no chronic pathology 
of the upper respiratory tract in the anamnesis and did not 
receive any medical therapy within a month before the 
examination. 
 To conduct laser tonsillotomy, a high-energy 
laser semiconductor device "Lasermed-10-01" was used at a 
wavelength of 1.06 μm and a power density of 7-8 mW/cm2. 
Patients underwent premedication and local infiltrative 
anesthesia in the paratonsillar tissue. A laser with preset 
parameters in the contact mode with the help of a light guide 
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was used to cut off the lacerated surface of the tonsils. 
Duration of bilateral tonsillotomy with anesthesia was 
roughly 15-20 minutes. 
 Patient in group B had sublingual Ismigen 
postoperatively: once daily for a period for a period of 10 
days [11]. 
Microbiological examination of the material from 
the mucous membranes of the tonsils or oropharynx was 
carried out in dynamics before the treatment, 7 days after the 
treatment and 1-2 months after the end of the course of 
treatment. Determination of the qualitative and quantitative 
composition of the microbiocenosis of the studied biotope 
was carried out in accordance with the current normative 
documents according to generally accepted methods. 
Identification of isolated bacterial cultures was carried out 
according to morphological, cultural, biochemical features in 
accordance with the «Determinant (identifier) of Bacteria 
Berdgi», identification of fungal strains - according to «The 
determinant of pathogenic and opportunistic fungi». The 
results of determining the number of microorganisms 
(colony forming units) were expressed in decimal logarithms 
per gram of clinical material – lg CFU/g. 
 A comprehensive assessment of the status of the 
oropharynx microbiocenosis was carried out in accordance 
with the criteria described earlier [12]. According to these 
criteria, the status of the microbiocenosis of the oropharynx 
was divided into: eubiosis, dysbiosis of the 1st degree, 
dysbiosis of the 2nd degree and dysbiosis of the 3rd degree. 
 Statistical processing of the data was carried out 
using the Statistics-8 software package, Microsoft Office 
Excel 2003. 
Results and discussion 
 The main method of treatment of the 
decompensated stage of chronic tonsillitis for a long time 
was (and in the routine practice remains) the classical 
method: total removal of palatine tonsils. However, due to 
the expansion of knowledge about the fundamentals of 
immunophysiology of the tonsils, the tonsillar problem in its 
clinical aspect shifted towards a sparing attitude towards the 
lymphoepithelial structures of the mouth and nasopharynx, 
as special formations of the immune system called "border 
lymphoid tissue" associated with mucosal immunity [13]. 
Laser tonsillotomy just refers to organ-sparing methods of 
treatment of CDT. 
 To assess the effectiveness of the effects of 
various treatment regimens for patients with CDT on the 
state of the oropharynx microbiocenosis, an integrated 
approach to the assessment of microflora was used, which 
makes it possible to describe the communities that make up 
the microbiotic component of the studied ecosystem. The 
generalized results of the distribution of patients with CDT 
and controls of the above-mentioned degrees of dysbiosis 
and their dynamics under the influence of various treatment 
methods are presented in Table 1. 
 
 
Table 1. Dynamics of changes in the state of the oropharyngeal microbiocenosis in patients with chronic decompensated 
tonsillitis using various methods of treatment 
Patient 
Groups 
Terms of 
Examination of 
patients 
Specificity (%) of patients in groups with 
Eubiosis 
Dysbiosis 
1-degree 
Dysbiosis 
2-degree 
Dysbiosis 
3-degree 
Laser Tonsilotomy 
(gp. А, n=15) 
Before treatment 0 7,1 32,9 60,0 
After treatment 46,7 40,0 13,3 0 
1-2 months after 
treatment 
26,7 53,3 20,0 0 
Laser Tonsilotomy + 
Ismigen  
(gp. В, n=16) 
Before treatment 0 6,3 32,3 62,5 
After treatment 62,1 31,6 6,3 0 
1-2 months after 
treatment 
81,3 18,7 0 0 
Control group 
(n=17) 
88,2 11,8 0 0 
 
 Before treatment, in the decompensated state of 
CT (59.7±2.8)% of the examined subjects was accompanied 
by dysbiotic manifestations and were classified to grade 3: 
60.0% of patients in group A and in 62.5% of patients in 
group B. In no case pathology of the tonsils did not reveal 
the microbiological picture of eubiosis. In the control group, 
the microbial representatives of eubiosis colonized the 
surveyed biotope in 88.2% of practically healthy individuals. 
 Carrying out various types of therapeutic 
measures for patients with CDT positively affected the 
microbiocenosis status of the studied biotope in comparison 
with the initial data. 
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 In the first week after the treatment, all subjects 
surveyed had almost no dysbiotic condition of grade 3. The 
proportion of patients who had eubiosis or compensated 
dysbiosis a week after the end of treatment in groups A and 
B was 86.7-93.7%, respectively. 
 More clearly, the difference between different 
methods of treatment of patients with CDT manifested itself 
after 1-2 months. In patients who underwent laser 
tonsillotomy with further immunomodulation with bacterial 
lysates, the microbial communities of the mucous 
membranes of preserved tonsils did not statistically differ 
from the microbiota of the control group of practically 
healthy individuals: in 81.3% of patients Eubiosis was 
established in groups and 18.7% in dysbiosis 1st degree. In 
persons without pathology of the tonsils, these indicators 
were 88.2% and 11.8%, respectively. 
 Comparison of the results of microbiological 
examination of patients in groups A and B showed the 
advantages of using immunocorrection after laser 
tonsillotomy. Thus, in 81.3% of the examined group B 
microbiocenoses of the mucous membranes of preserved 
tonsils are represented by eubiosis, compared with 26.7% in 
group A (p<0.01). The rest of the patients (18.7%) of group 
B showed dysbiotic phenomena of 1st degree, against 53.3% 
of persons in group A (p<0.05). 
 The study of the species composition of the 
oropharynx microbiota of patients with CDT before 
treatment and its comparison with bacterial antigens that are 
part of the preparation of Ismigen showed that practically 
every patient had persistent one or two respiratory 
pathogens, which are eliminated by bacterial lysates of 
Ismigen. Thus, in 46.7-50.0% of patients, pyogenic 
streptococci were isolated, the colonization density of which 
with mucous membranes was lg (6.2±0.4) CFU/g; 
Staphylococcus aureus was found in 37.5-40.0% of the 
patients examined in an average of lg (5.5±0.6) CFU/g; the 
presence of Klebsiella was found in 37.5-40.0% of patients 
(log (5.5±0.6) CFU/g); haemophilus and moraxelles in 20.0-
33.3% of cases were excreted in the amount of lg (7.2±0.4) 
CFU/g and lg (4.9±0.3) CFU/g, respectively. 
 Immediately after the treatment, there were no 
significant differences in the incidence of the above-
mentioned bacteria between groups of patients (Figures 1-5). 
Respiratory pathogens were detected in 5 patients of group 
A and 3 patients of group B. The density of seeding of the 
biotope decreased significantly compared to baseline values 
and averaged lg (4.1±0.2) CFU/g (p <0.01). 
 1-2 months after the treatment in none of the 
patients who received the preparation of «Ismigen», the 
indicated bacteria were detected in the microbiocenosis of 
the mucous tonsils, against 66.7% of the group A patients 
who did not undergo sublingual immunization (p<0.01) (Fig. 
1-5). «Sanitizing», with respect to the microbial factor of CT, 
the effectiveness of performed tonsillotomy in a third of 
patients of group A was lost. 
 The aforementioned respiratory pathogens are 
most often encountered in chronic inflammatory processes in 
the upper respiratory tract. Long-term persistence of 
microorganisms is accompanied by aggravation of 
immunological disorders and an increased risk of recurrence 
of the disease [14]. Our studies confirmed the above for 
patients in Group A, who underwent adequate pat 
hogenetic organ-sparing treatment of the tonsils, but without 
subsequent immunocorrection. 
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Fig. 1. The frequency of allocation of Staphylococcus aureus from the mucous membranes of palatine tonsils in 
dynamics, depending on the ongoing treatment of patients with CDT. 
 
 
 
 gr. A. Laser Tonsillotomy;  
  
 gr. B. Laser Tonsillotomy + Ismigen 
 
Fig. 2. The frequency of allocation of Streptococcus pyogenes from the mucous membranes of palatine tonsils in 
dynamics, depending on the ongoing treatment of patients with CDT. 
 
 
 
 gr. A. Laser Tonsillotomy;  
  
 gr. B. Laser Tonsillotomy + Ismigen 
 
0
5
10
15
20
25
30
35
40
45
50
1 2 3
46,7
13,3
20
50
6,3
0
A
llo
ca
te
d
 F
re
q
u
e
n
cy
, %
Allocated Dynamics: 1 - before treatment, 2 - after treatment, 3 - 1-2 months 
after treatment
STREPTOCOCCUS PYOGENES
0
5
10
15
20
25
30
35
40
1 2 3
40
6,7
13,3
37,5
0 0
A
llo
ca
te
d
 F
re
q
u
e
n
cy
, %
Allocated Dynamics: 1 - before treament, 2 - after treatment, 3 - 1-2 months 
after treatment
KLEBSIELLA PNEUMONIAE
Annals of Mechnikov Institute, N 4, 2017 
www.imiamn.org.ua /journal.htm                                                                      50 
 
DOI: 10.5281/zenodo.1133777 
Fig. 3. The frequency of allocation of Klebsiella pneumoniae from the mucous membranes of palatine tonsils in 
dynamics, depending on the ongoing treatment of patients with CDT. 
 
 
 
 
 gr. A. Laser Tonsillotomy;  
  
 gr. B. Laser Tonsillotomy + Ismigen 
 
Fig. 4. The frequency of allocation of Haemophilus influenzae from the mucous membranes of palatine tonsils in 
dynamics, depending on the ongoing treatment of patients with CDT. 
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Fig. 5. The frequency of allocation of Moraxella catarrhalis from the mucous membranes of palatine tonsils in dynamics, 
depending on the ongoing treatment of patients with CDT. 
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Conclusions. 
1. Ismigen, administered to patients with chronic 
decompensated tonsillitis as part of complex treatment 
provided a more pronounced antimicrobial effect and 
promoted restoration of the normocoenosis of the 
oropharynx. 
2. Laser tonsillotomy performed with further 
immunomodulation with the help of immunostimulant on the 
basis of bacterial lysates Ismigen, allows to achieve the 
indices of microbial communities of the mucous membranes 
of preserved tonsils, which did not differ statistically from 
the microbiota of the control group of practically healthy 
persons: in 81.3% of patients, eubiosis and in 18.7% of the 
dysbiosis of the 1st degree. In persons without pathology of 
the tonsils, these indicators were 88.2% and 11.8%, 
respectively. 
3. Ismigen has a selective antimicrobial effect against the 
most common respiratory pathogens, which is objectively 
manifested by the restoration of the eubiotic colonization 
profile of the oropharynx in patients with CDT 1-2 months 
after treatment. 
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Introduction 
Chronic tonsillitis (CT) occupies a leading place in the 
structure of general Oto-rhino-laryngology (ORL) 
pathology which is characterized by a tendency to an 
increase in the number of patients with recurrent course, the 
development of complications and the diversity of 
etiopathogenetic mechanisms of onset. It has been 
established that the most acceptable tactic for the 
prevention of exacerbations of chronic tonsillitis is the use 
of various groups of drugs that enhance the humoral 
immunity of the mucous membranes. The drug Ismigen is 
an immunostimulant based on a bacterial lysate, which 
increases the body's resistance to infections due to an 
increase in serum and secretory antibodies, activation of 
cellular and humoral factors of nonspecific immunity.  The 
aim of the study was to evaluate the effectiveness of the 
use of Ismigen in the complex treatment of patients with 
chronic decompensated tonsillitis by studying the dynamics 
of microbiological indicators. Materials and methods. To 
achieve this goal, 31 patients with chronic decompensated 
tonsillitis (CDT) were examined. Patients were divided into 
2 groups depending on the proposed treatment regimen: 
Group A: patients with chronic decompensated tonsillitis 
who underwent laser tonsillotomy - 15 patients; Group B: 
patients with chronic decompensated tonsillitis who 
underwent laser tonsillotomy with further 
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immunostimulation with the drug Ismigen - 16 patients. 
The control group (CG) consisted of 17 practically healthy 
individual. Patient in group B had sublingual Ismigen 
postoperatively: once daily for a period for a period of 10 
days. Microbiological examination of the material from the 
mucous membranes of the tonsils or oropharynx was 
carried out in dynamics before the treatment, 7 days after 
the treatment and 1-2 months after the end of the course of 
treatment.  A comprehensive assessment of the status of the 
oropharynx microbiocenosis was carried out in accordance 
with the criteria described earlier. According to these 
criteria, the status of the microbiocenosis of the oropharynx 
was divided into: eubiosis, dysbiosis of the 1st degree, 
dysbiosis of the 2nd degree and dysbiosis of the 3rd degree. 
Results and discussion.  Before treatment, in the 
decompensated state of CT (59.7±2.8) % of the examined 
subjects was accompanied by dysbiotic manifestations and 
were classified to grade 3: 60.0% of patients in group A and 
in 62.5% of patients in group B. In no case pathology of the 
tonsils did not reveal the microbiological picture of 
eubiosis. Carrying out various types of therapeutic 
measures for patients with CDT positively affected the 
microbiocenosis status of the studied biotope in comparison 
with the initial data. Comparison of the results of 
microbiological examination of patients in groups A and B 
showed the advantages of using immunocorrection after 
laser tonsillotomy. Thus, in 81.3% of the examined group B 
microbiocenoses of the mucous membranes of preserved 
tonsils are represented by eubiosis, compared with 26.7% in 
group A (p<0.01). The rest of the patients (18.7%) of group 
B showed dysbiotic phenomena of 1st degree, against 53.3% 
of persons in group A (p<0.05). The study of the species 
composition of the oropharynx microbiota of patients with 
CDT before treatment and its comparison with bacterial 
antigens that are part of the preparation of Ismigen showed 
that practically every patient had persistent one or two 
respiratory pathogens, which are eliminated by bacterial 
lysates of Ismigen. Immediately after the treatment, 
there were no significant differences in the incidence of the 
above-mentioned bacteria between groups of patients. 
Respiratory pathogens were detected in 5 patients of group 
A and 3 patients of group B. The density of seeding of the 
biotope decreased significantly compared to baseline values 
and averaged lg (4.1±0.2) CFU/g (p <0.01). 1-2 months 
after the treatment in none of the patients who received the 
preparation of «Ismigen», the indicated bacteria were 
detected in the microbiocenosis of the mucous tonsils, 
against 66.7% of the group A patients who did not undergo 
sublingual immunization (p<0.01) . «Sanitizing», with 
respect to the microbial factor of CT, the effectiveness of 
performed tonsillotomy in a third of patients of group A 
was lost. The aforementioned respiratory pathogens are 
most often encountered in chronic inflammatory processes 
in the upper respiratory tract. Long-term persistence of 
microorganisms is accompanied by aggravation of 
immunological disorders and an increased risk of 
recurrence of the disease [14]. Our studies confirmed the 
above for patients in Group A, who underwent adequate 
pathogenetic organ-sparing treatment of the tonsils, but 
without subsequent immunocorrection. 
Conclusions. 1. Ismigen, administered to patients with 
chronic decompensated tonsillitis as part of complex 
treatment provided a more pronounced antimicrobial effect 
and promoted restoration of the normocoenosis of the 
oropharynx. 2. Laser tonsillotomy performed with further 
immunomodulation with the help of immunostimulant on 
the basis of bacterial lysates Ismigen, allows to achieve the 
indices of microbial communities of the mucous 
membranes of preserved tonsils, which did not differ 
statistically from the microbiota of the control group of 
practically healthy persons: in 81.3% of patients, eubiosis 
and in 18.7% of the dysbiosis of the 1st degree. In persons 
without pathology of the tonsils, these indicators were 
88.2% and 11.8%, respectively. 3. Ismigen has a selective 
antimicrobial effect against the most common respiratory 
pathogens, which is objectively manifested by the 
restoration of the eubiotic colonization profile of the 
oropharynx in patients with CDT 1-2 months after 
treatment. 
Keywords: chronic decompensated tonsillitis, complex 
treatment, Ismigen, microbiocenosis. 
 
